Qlife Holding AB (SE:QLIFE)
:QLIFE
QLIFE Stock Chart & Stats
kr3.01
-kr0.24(-7.59%)
At close: 4:00 PM EST
kr3.01
-kr0.24(-7.59%)
Day’s Range― - ―
52-Week Rangekr1.20 - kr5.70
Previous CloseN/A
Volume24.68K
Average Volume (3M)97.19K
Market Cap
kr61.50M
Enterprise Valuekr33.68M
Total Cash (Recent Filing)kr1.42M
Total Debt (Recent Filing)kr8.55M
Price to Earnings (P/E)―
Beta1.60
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding28,874,178
10 Day Avg. Volume81,486
30 Day Avg. Volume97,188
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-4.74
Price to Sales (P/S)109.73
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-126.16
Revenue Forecast (FY)kr116.00M
Bulls Say, Bears Say
Bulls Say
Decentralized Diagnostics PlatformQlife’s proprietary platform targets rapid, near-patient molecular diagnostics and consumables, aligning with long-term decentralization of testing. This creates potential recurring consumable revenue, platform stickiness and product ecosystem advantages that can sustain demand over time.
Material DeleveragingSignificant reduction in debt materially lowers interest and refinancing pressure, improving financial flexibility. Deleveraging strengthens the company’s ability to survive near-term headwinds and increases optionality to raise non-dilutive or better-priced capital for operational recovery.
Improving Cash Outflows And Narrower LossesOperating cash outflows and headline losses have trended smaller versus prior peaks, reflecting cost control and execution on restructuring. Sustained improvement in cash burn increases the probability of reaching breakeven if revenue or commercialization momentum recovers.
Bears Say
Collapsed RevenueRevenue collapse to a negligible base destroys operating leverage and undermines the business model’s scalability. With revenue tiny relative to historical levels and fixed costs, organic cash generation is insufficient, making sustainable recovery highly dependent on successful commercial re‑entry or external capital.
Negative Equity And Fragile Balance SheetNegative equity and a sharply contracted asset base reduce loss-absorbing capacity and raise going‑concern and refinancing risks. This fragility limits strategic flexibility, can deter partners/customers, and increases the likelihood the company must access dilutive or costly funding to continue operations.
Persistent Operating Cash BurnConsistent negative operating cash flow and repeated negative free cash flow indicate ongoing reliance on external financing. Persistent burn constrains R&D and commercialization investment, elevates dilution risk and threatens continuity absent a durable improvement in revenue or new financing sources.
QLIFE FAQ
What was Qlife Holding AB’s price range in the past 12 months?
Qlife Holding AB lowest stock price was kr1.20 and its highest was kr5.70 in the past 12 months.
What is Qlife Holding AB’s market cap?
Qlife Holding AB’s market cap is kr61.50M.
When is Qlife Holding AB’s upcoming earnings report date?
Qlife Holding AB’s upcoming earnings report date is May 21, 2026 which is in 41 days.
How were Qlife Holding AB’s earnings last quarter?
Qlife Holding AB released its earnings results on Feb 11, 2026. The company reported -kr0.185 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.185.
Is Qlife Holding AB overvalued?
According to Wall Street analysts Qlife Holding AB’s price is currently Overvalued.
Does Qlife Holding AB pay dividends?
Qlife Holding AB does not currently pay dividends.
What is Qlife Holding AB’s EPS estimate?
Qlife Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qlife Holding AB have?
Qlife Holding AB has 28,874,178 shares outstanding.
What happened to Qlife Holding AB’s price movement after its last earnings report?
Qlife Holding AB reported an EPS of -kr0.185 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.945%.
Which hedge fund is a major shareholder of Qlife Holding AB?
Currently, no hedge funds are holding shares in SE:QLIFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qlife Holding AB
Qlife Holding AB (QLIFE) is a biotechnology company based in Sweden, specializing in the development of advanced diagnostic tools aimed at improving patient care and health outcomes. The company focuses on innovative solutions in the healthcare sector, particularly in the areas of personalized medicine and point-of-care diagnostics. Qlife's core products include its proprietary diagnostic platforms, which utilize advanced technology to deliver rapid and accurate health assessments.